APA (7th ed.) Citation

Christopher, C., Nwogoh, B., Akaba, K., igwilo, H., & Abang, R. (2022). Plasminogen Activator Inhibitor 1 (PAI-1) and Haematologic Parameters in HIV- Positive Patients on Protease Inhibitor-Based HAART Regimen: A Case-Control Study. Clinical and applied thrombosis/hemostasis, 28, 10760296221126176. https://doi.org/10.1177/10760296221126176

Chicago Style (17th ed.) Citation

Christopher, Chimeziem, Benedict Nwogoh, Kingsley Akaba, Hilary igwilo, and Roger Abang. "Plasminogen Activator Inhibitor 1 (PAI-1) and Haematologic Parameters in HIV- Positive Patients on Protease Inhibitor-Based HAART Regimen: A Case-Control Study." Clinical and Applied Thrombosis/hemostasis 28 (2022): 10760296221126176. https://doi.org/10.1177/10760296221126176.

MLA (9th ed.) Citation

Christopher, Chimeziem, et al. "Plasminogen Activator Inhibitor 1 (PAI-1) and Haematologic Parameters in HIV- Positive Patients on Protease Inhibitor-Based HAART Regimen: A Case-Control Study." Clinical and Applied Thrombosis/hemostasis, vol. 28, 2022, p. 10760296221126176, https://doi.org/10.1177/10760296221126176.